Rationale for immune checkpoint inhibitors plus targeted therapy for advanced renal cell carcinoma
The mechanism of action of targeted agents and immune checkpoint inhibitors and the synergistic effect of their combined treatment. The combination of VEGF and VEGFR activates PI3K-AKT-mTOR signaling pathway, which further promotes the progress of tumor cells. The hypoxia environment of tumor cells and the inactivation of VHL gene lead to the increase of HIF-1α and HIF-1β heterodimers, which further activates the signal transduction pathway. The presence of VEGF enhances the function of Tregs and MDSCs and inhibits the maturation of DCs, ultimately leading to suppression of T-cell activation.Targeted therapeutic drugs can effectively inhibit VEGF and its signalling pathways and exert an anti-tumour effect. CTLA-4 and CD28 on T cells can compete with B7 ligands (CD80 and CD86) expressed on APC. However, the affinity of CTLA-4 to B7 ligands is significantly higher than that of CD28, which can induce downstream inhibition signals and inhibit T cell activation. Tumor cells can use the interaction of PD-1 and PD-L1/L2 to release inhibitory signals to escape antigen-specific T cell immune response. Immune checkpoint inhibitors against CTLA-4 and PD-1/PD-L1 can restore effective anti-tumor immunity. It is clear from the above that the use of target agents enhances the anti-tumour activity of the immune system, thereby increasing the efficacy of immune checkpoint inhibitors, and therefore they have a synergistic effect.
Publication
Rationale for immune checkpoint inhibitors plus targeted therapy for advanced renal cell carcinoma. (2024) Siwei Yang, et al. Heliyon. 2024 Apr 15;10(7):e29215. Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Homo sapiens | Primates | VHL | VHL | ncbigene_symbol | VHL | 7428 |
| Homo sapiens | Primates | HIF-1a | HIF-1A | ncbigene_synonym | HIF1A | 3091 |
| Homo sapiens | Primates | HIF-1ẞ | HIF1 | ncbigene_synonym | SETD2 | 29072 |
| Homo sapiens | Primates | HIF-1ẞ | HIF1 | famplex_relations | ARNT | 405 |
| Homo sapiens | Primates | Akt | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | Akt | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | Akt | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | VEGF-R | VEGFR | ncbigene_synonym | KDR | 3791 |
| Homo sapiens | Primates | VEGF-R | VEGFR | famplex_relations | FLT1 | 2321 |
| Homo sapiens | Primates | VEGF-R | VEGFR | famplex_relations | FLT4 | 2324 |
| Homo sapiens | Primates | MSCs | MSC | ncbigene_symbol | MSC | 9242 |
| Homo sapiens | Primates | MSCs | MSC | ncbigene_synonym | SLC25A37 | 51312 |
| Homo sapiens | Primates | VEGF | VEGF | ncbigene_synonym | VEGFA | 7422 |
| Homo sapiens | Primates | VEGF | VEGF | famplex_relations | VEGFB | 7423 |
| Homo sapiens | Primates | VEGF | VEGF | famplex_relations | VEGFC | 7424 |
| Homo sapiens | Primates | VEGF | VEGF | famplex_relations | VEGFD | 2277 |
| Homo sapiens | Primates | VEGF | VEGF | famplex_relations | PGF | 5228 |
| Homo sapiens | Primates | PD-L1 | PD-L1 | ncbigene_synonym | CD274 | 29126 |
| Homo sapiens | Primates | APC | APC | ncbigene_symbol | APC | 324 |
| Homo sapiens | Primates | APC | APC | ncbigene_synonym | PROC | 5624 |
| Homo sapiens | Primates | PD-L1/L2 | PD-L2 | ncbigene_synonym | PDCD1LG2 | 80380 |
| Homo sapiens | Primates | PD-I | PDI | ncbigene_synonym | P4HB | 5034 |
| Homo sapiens | Primates | PD-I | PDI | ncbigene_synonym | PADI1 | 29943 |
| Homo sapiens | Primates | PD-I | PDI | ncbigene_synonym | PDIA2 | 64714 |
| Homo sapiens | Primates | MHC | MHC | ncbigene_synonym | HLA-C | 3107 |
| Homo sapiens | Primates | TCR | TCR | ncbigene_synonym | TRBV20OR9-2 | 6962 |
| Homo sapiens | Primates | TCR | TCR | famplex_relations | TRA | 6955 |
| Homo sapiens | Primates | TCR | TCR | famplex_relations | TRB | 6957 |
| Homo sapiens | Primates | TCR | TCR | famplex_relations | TRD | 6964 |
| Homo sapiens | Primates | TCR | TCR | famplex_relations | TRG | 6965 |
| Homo sapiens | Primates | PD-1 | PD-1 | ncbigene_synonym | PDCD1 | 5133 |
| Homo sapiens | Primates | PD-1 | PD-1 | ncbigene_synonym | RPL17 | 6139 |
| Homo sapiens | Primates | PD-1 | PD-1 | ncbigene_synonym | RPL17-C18orf32 | 100526842 |
| Homo sapiens | Primates | CD28 | CD28 | ncbigene_symbol | CD28 | 940 |
| Homo sapiens | Primates | CTLA-4 | CTLA-4 | ncbigene_synonym | CTLA4 | 1493 |
| Homo sapiens | Primates | Zap70 | ZAP70 | ncbigene_symbol | ZAP70 | 7535 |
| Homo sapiens | Primates | SHP-2 | SHP2 | ncbigene_synonym | PTPN11 | 5781 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | KRAS | 3845 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | HRAS | 3265 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | NRAS | 4893 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFATC1 | 4772 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFATC2 | 4773 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFATC3 | 4775 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFATC4 | 4776 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFAT5 | 10725 |
| Homo sapiens | Primates | PKC | PKC | ncbigene_synonym | PRRT2 | 112476 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCA | 5578 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCB | 5579 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCD | 5580 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCE | 5581 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCG | 5582 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCH | 5583 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCI | 5584 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCQ | 5588 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCZ | 5590 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKD3 | 23683 |
| Homo sapiens | Primates | ERK | ERK | ncbigene_synonym | EPHB2 | 2048 |
| Homo sapiens | Primates | ERK | ERK | ncbigene_synonym | MAPK1 | 5594 |
| Homo sapiens | Primates | ERK | ERK | famplex_relations | MAPK3 | 5595 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Danio rerio | Vertebrates | mTOR | MTOR | ncbigene_symbol | mtor | 324254 |
| Danio rerio | Vertebrates | VHL | VHL | ncbigene_symbol | vhl | 791202 |
| Danio rerio | Vertebrates | HIF-1a | HIF1A | ncbigene_synonym | hif1ab | 393202 |
| Danio rerio | Vertebrates | MSCs | MSC | ncbigene_symbol | msc | 556396 |
| Danio rerio | Vertebrates | VEGF | VEGF | ncbigene_synonym | vegfaa | 30682 |
| Danio rerio | Vertebrates | PD-L1 | PDL1 | ncbigene_synonym | si:ch211-241b2.5 | 100536137 |
| Danio rerio | Vertebrates | APC | APC | ncbigene_symbol | apc | 386762 |
| Danio rerio | Vertebrates | CD28 | CD28 | ncbigene_symbol | cd28 | 101886406 |
| Danio rerio | Vertebrates | Zap70 | ZAP70 | ncbigene_symbol | zap70 | 553615 |
| Danio rerio | Vertebrates | SHP-2 | SHP2 | ncbigene_synonym | ptpn11a | 333979 |
| Danio rerio | Vertebrates | RAS | RAS | ncbigene_synonym | rab1ab | 368883 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Pazopanib | pazopanib | 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide | chebi:71219 | |
| DCs | DCS | (4R)-4-aminoisoxazolidin-3-one | chebi:40009 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|